|
The
Sonablate® 500
 The
Sonablate is a minimally invasive medical device designed to
treat prostate cancer with HIFU energy. By way of a transrectal
probe, the Sonablate captures real-time images of the prostate
gland allowing the treating physician to create a customised
treatment plan for each patient. The physician then uses the
Sonablate to deliver the ultrasound energy to extremely small
target sites, or focal points, throughout the prostate gland.
Features of the Sonablate system include:
- Only
HIFU device for treating prostate cancer that does not require
an advance surgical procedure (known as a TURP) in order
to achieve effective results for enlarged prostates up to
40 grams.
- Treating physicians are in control
of the Sonablate’s power settings and can adjust them based
on real-time feedback after delivery of the ultrasound energy
by using an innovative software feature known as TCM, or
tissue change monitoring.
- Each lesion produced by the Sonablate’s
energy delivery is 10-12mm in length, smaller than other
prostate cancer HIFU devices, which allows for greater precision
and conformity in small, critical spaces around the gland.
- The Sonablate has real-time, three-dimensional
imaging, enabling the physician to detect even slight movement
of the device or gland, which could compromise treatment.
- The Sonablate uses a fully integrated
probe with two transducers, one to image the prostate gland
and the other to treat with HIFU.
Visually
Guided HIFU
Tissue Change Monitoring
Software (TCM)
TCM is a unique software designed for the Sonablate that monitors real-time tissue
changes during HIFU therapy for the treatment of malignant and benign prostate
disease. TCM provides feedback on the treatment in real-time so that the surgeon
knows exactly what is happening to the prostate tissue during HIFU. TCM has the
potential to reduce side effects for patients because physicians can tailor the
amount of heat used for each individual patient.
How does TCM work?
A radio frequency (RF) signal is sent to a treatment site prior to delivery of
HIFU and then another signal is sent after delivery of HIFU in the same treatment
site. TCM calculates the change that took place and displays it on-screen. TCM
quantifies tissue changes based on a comparison of radio frequency (RF) ultrasound
pulse-echo signals at each treatment sites.
Click here to download the TCM brochure.
|
